Susan S. Smyth

High Impact

Researcher

UAMS

Formerly Arkansas Affiliated with UAMS through 2024.

Faculty Researcher

20 h-index 78 pubs 1,739 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Susan S. Smyth's research group at the University of Arkansas for Medical Sciences investigates thrombotic risk and related biomarkers, particularly in the context of COVID-19. Her work has explored novel biomarkers for thrombotic risk in patients with COVID-19, contributing to consensus statements on the topic. She has also studied the role of extracellular histones in triggering disseminated intravascular coagulation and the impact of specific medications, such as ticagrelor and clopidogrel, on platelet aggregation in patients with chronic kidney disease.

Beyond thrombosis, Smyth's research has extended to the implementation of clinical practice guidelines, including syncope evaluation in emergency departments, and patient expectations for syncope management. Her work also touches on career development in translational science and the organizational aspects of menopause in the workplace. Smyth has a h-index of 20 and has authored 78 publications with over 1,700 citations, indicating a significant contribution to her fields of study. She has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Jerry Ware and Nishank Jain.

Metrics

h-index: 20
Publications: 78
Citations: 1,739

Selected Publications

Neurotensin accelerates atherosclerosis and increases circulating levels of short-chain and saturated triglycerides (2024)

Atherosclerosis 5 citations DOI OpenAlex
438 Platelets, Inflammation and Thrombosis in Chronic Kidney Disease (2023)

Journal of Clinical and Translational Science DOI OpenAlex
Co-designing and piloting educational materials with patients and healthcare providers for syncope in the emergency department (2023)

PEC Innovation 5 citations DOI OpenAlex
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease (2023)

Vascular Pharmacology 12 citations DOI OpenAlex
Abstract 487: Extracellularhistonestrigger Disseminated Intravascular Coagulation By Lytic Cell Death (2022)

Arteriosclerosis Thrombosis and Vascular Biology DOI OpenAlex
Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death (2022)

International Journal of Molecular Sciences 17 citations DOI OpenAlex
Trends and Outcomes of Oral Anticoagulation With Direct Current Cardioversion for Atrial Fibrillation/Flutter at an Academic Medical Center (2022)

Cardiology Research 4 citations DOI OpenAlex
Bioactive lipids and metabolic syndrome—a symposium report (2022)

Annals of the New York Academy of Sciences 12 citations DOI OpenAlex
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium (2022)

Nature Reviews Cardiology 295 citations DOI OpenAlex
KL2 scholars’ perceptions of factors contributing to sustained translational science career success (2021)

Journal of Clinical and Translational Science 17 citations DOI OpenAlex
Developing and Demonstrating the Viability and Availability of the Multilevel Implementation Strategy for Syncope Optimal Care Through Engagement (MISSION) Syncope App: Evidence-Based Clinical Decision Support Tool (2021)

Journal of Medical Internet Research 7 citations DOI OpenAlex
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles (2021)

Journal of Thrombosis and Thrombolysis 17 citations DOI OpenAlex